Claims for Patent: 8,846,396

Summary for Patent: 8,846,396

Title:	Methods for the isolation of cardiac stem cells
Abstract:	Method for the isolation, expansion and preservation of cardiac stem cells from human or animal tissue biopsy samples to be employed in cell transplantation and functional repair of the myocardium or other organs. Cells may also be used in gene therapy for treating cardiomyopathies, for treating ischemic heart diseases and for setting in vitro models to study drugs.
Inventor(s):	Giacomello; Alessandro (Rome, IT), Messina; Elisa (Rome, IT), Battaglia; Massimo (Rome, IT), Frati; Giacomo (Rome, IT)
Assignee:	Universita Degli Studi Di Roma \"La Sapienza\" (Rome, IT)
Application Number:	13/214,680
Patent Claims:	1. A method for isolating cardiospheres from a cardiac tissue biopsy sample, said method comprising the following steps: fragmenting a cardiac tissue biopsy sample to generate a plurality of cardiac tissue fragments, wherein the cardiac tissue biopsy sample is a non-embryonic cardiac tissue obtained from the ventricle, atrium or auricle of a heart; removing non-cardiac tissue and non-cardiac cells from said cardiac tissue fragments by partial enzymatic digestion; culturing said partially digested cardiac tissue fragments in a first culture media until phase-bright cells migrate from said partially digested cardiac tissue fragments; collecting said phase-bright cells; culturing said phase-bright cells in a second culture media on a polylysine treated surface to generate one or more cardiospheres; wherein said cardiospheres are spheroid structure of about 20 .mu.m to about 150 .mu.m in culture, wherein said cardiospheres are multicellular aggregates comprising stem cells, cardiac cells, and endothelial cells, wherein said stem cells express one or more stem cell markers selected from the group consisting of CD-34, ckit, and sca-1 within 12 hours of said cardiospheres being generated, wherein said endothelial cells express one or more endothelial markers selected from the group consisting of KDR, flk-1 and CD31 within 12 hours of said cardiospheres being generated; and harvesting said one or more cardiospheres. 2. The method of claim 1, wherein said fragmenting results in said cardiac tissue fragments of a size allowing diffusion of nutrients in a culture media to the fragments. 3. The method of claim 1, wherein said removing comprises enzymatic digestion and is performed using trypsin, collagenase, or combinations thereof. 4. The method of claim 1, wherein said second culture media comprises one or more of epidermal growth factor (EGF), fibroblast growth factor (FGF), cardiotropin-1, and thrombin. 5. The method of claim 1, further comprising disaggregating said harvested cardiospheres to generate disaggregated cells and culturing said disaggregated cells in said second culture media to generate additional cardiospheres, thereby expanding the population of cardiac stem cells. 6. The method of claim 5, wherein said disaggregated cells are cultured on said treated growth surface. 7. The method of claim 1, wherein said collecting comprises trysinization of the partially digested cardiac tissue fragments and the phase-bright cells. 8. The method of claim 1, wherein said first culture media comprises about 10% serum. 9. The method of claim 1, wherein said second culture media comprises serum and a serum substitute. 10. The method of claim 9, wherein said serum substitute comprises B27. 11. The method of claim 1, wherein said second culture media is horse serum free. 12. The method of claim 11, wherein said second culture media further comprises growth factors.

Details for Patent 8,846,396

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2023-07-31